Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan Discontinuation in Advanced Colorectal Cancer
NCT00320320Phase 2Terminated
- Sponsor
- Gachon University Gil Medical Center
- Start
- Apr 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by Gachon University Gil Medical Center. Started Apr 2005; status: terminated.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00320320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320320.